| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-17 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-15 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-10 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 6e-06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |